Olfatifar Meysam, Rafiei Fariba, Sadeghi Amir, Ataei Elnaz, Habibi Mohammad Amin, Pezeshgi Modarres Mehdi, Ghalavand Zohreh, Houri Hamidreza
Gastroenterology and Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, Iran.
Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Shahid Arabi Ave., Yemen St., Velenjak, P.O. BOX: 1985717411, Tehran, Iran.
J Epidemiol Glob Health. 2025 Jan 20;15(1):5. doi: 10.1007/s44197-025-00348-3.
Colorectal cancer (CRC) has become a significant global concern, presenting formidable challenges to healthcare systems and leading to substantial healthcare expenses. This study examines the projected prevalence and trends of CRC worldwide, encompassing 21 regions and 195 nations.
We employed an illness-death model (IDM) in order to forecast the anticipated prevalence of CRC by the year 2040. To accomplish this, we utilized data retrieved from the Global Health Data Exchange (GHDx) query tool spanning from 1990 to 2021. The primary objective of this study is to furnish sex-specific estimations encompassing various geographical regions.
By 2040, the global age-standardized prevalence rate (ASPR) of CRC among the total population is projected to rise, reaching 145.82 per 100,000, which reflects an increase of 8.15%. East Asia is forecasted to have the highest ASPR at 330.17 per 100,000, representing a substantial rise of 94.81%. Notably, the most rapid percentage increase is projected in Andean Latin America, with an anticipated rise of 106.2%. In contrast, many countries, particularly in developed nations, are expected to see a decline in ASPR during this period. The United Arab Emirates is projected to experience the most significant decrease in ASPR, at -86.51%, while Mauritius is anticipated to have the largest increase in CRC prevalence rate, at 226.26%. Globally and regionally, the ASPR among males is expected to remain higher than that among females over the next 21 years.
The global prevalence of CRC is increasing, particularly in developing countries, while developed countries are anticipated to observe a declining trend. This highlights the significance of appropriately allocating resources and implementing effective preventive measures, especially in developing nations.
结直肠癌(CRC)已成为全球重大关注问题,给医疗系统带来巨大挑战,并导致巨额医疗费用。本研究调查了全球21个地区和195个国家的结直肠癌预计患病率及趋势。
我们采用疾病死亡模型(IDM)来预测到2040年结直肠癌的预期患病率。为此,我们利用了从全球卫生数据交换(GHDx)查询工具获取的1990年至2021年的数据。本研究的主要目的是提供涵盖不同地理区域的按性别划分的估计值。
到2040年,预计全球总人口中结直肠癌的年龄标准化患病率(ASPR)将上升,达到每10万人145.82例,增幅为8.15%。预计东亚的ASPR最高,为每10万人330.17例,大幅上升94.81%。值得注意的是,预计安第斯拉丁美洲的百分比增幅最快,预计上升106.2%。相比之下,许多国家,尤其是发达国家,预计在此期间ASPR将下降。预计阿拉伯联合酋长国的ASPR下降幅度最大,为-86.51%,而毛里求斯的结直肠癌患病率预计增幅最大,为226.26%。在全球和区域层面,预计在未来21年中男性的ASPR将高于女性。
全球结直肠癌患病率正在上升,尤其是在发展中国家,而发达国家预计将呈下降趋势。这凸显了合理分配资源和实施有效预防措施的重要性,特别是在发展中国家。